Challenger (ASX:CGF) said that TAL Dai-ichi Life Australia (TAL) has secured all necessary regulatory approvals, including from the Australian Prudential Regulation Authority, enabling TAL to complete its acquisition of an equity stake in the company, according to a Friday filing with the Australian bourse.

Upon completion, TAL will own a 19.9% equity stake in Challenger, the filing said.